Career Center
Job Seekers, Welcome to AALAS Career Center
Search Filters
Use this area to filter your search results. Each filter option allows for multiple selections.
University of California Los Angeles
Los Angeles, California
Pennington Biomedical Research Center
Baton Rouge, Louisiana
Featured! Featured!
Quip Laboratories, Inc.
St. Louis, Missouri
University of Washington - Washington Regional Primate Research Center
Mesa, Arizona
University of Washington - Washington Regional Primate Research Center
Mesa, Arizona
University of Washington - Washington Regional Primate Research Center
Mesa, Arizona
Featured! Featured!
Loading... Please wait.
Job Saved
Save Job
Postdoctoral Scholar, Drug Discovery for Glioblastoma and other CNS malignancies
University of California Los Angeles
Details
Posted: 20-Apr-23
Location: Los Angeles, California
Type: Full-time
Salary: Open
Internal Number: 4109065
University of California Los Angeles
Requisition Number: JPF08383
The Brain Tumor Drug Discovery Program within the Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, is recruiting for a Postdoctoral Scholar to participate in drug discovery for brain tumors.
Candidates are expected to have extensive experience in drug discovery, in particular in areas of DMPK science, with preferred expertise in drug discovery for CNS applications. The candidate is expected to have significant technical and practical knowledge in DMPK, including the design and/or set up of in vitro assays to measure metabolic stability, metabolite ID, permeability and efflux, CYP450 assays, and hERG interactions. Experience working with in vitro kinase assays are also required. Moreover, the candidate should have considerable expertise in in vivo profiling of blood and tissue pharmacokinetics.
The Brain Tumor Drug Discovery Program at UCLA has established an integrated translational science program, bridging biology, molecular diagnostics, and drug discovery exclusively towards the discovery and development of new therapies for malignant brain tumors. This begins with an internationally recognized team of brain tumor investigators with expertise in biology (Nathanson), clinical trials (Cloughesy), drug discovery and development (Olivero and Jung), bioinformatics (Graeber) and molecular imaging (Ellingson and Czernin). This team has collectively developed multiple clinical drug candidates, including two that are currently in clinical trials for GBM patients, and designed and executed over 100 clinical trials for brain tumor patients. The program also includes a rich and unique resource of comprehensively characterized preclinical brain tumor models (~200 patient derived xenografts and gliomaspheres), state of the art instrumentation (e.g. Mass spectrometers, PET/CT, MRI) and nearly 4, 000 sq ft of total preclinical work space. Finally, the Program and its interdisciplinary team is well funded through both governmental and non-governmental funding sources, including the UCLA Brain Specialized Program of Research Excellence (SPORE).
To meet the Program's distinct and growing needs, the successful candidate will be responsible for the management of in-vitro and in-vivo preclinical ADME/PK for novel drug candidates; supervising and managing students, post-doctoral researchers and research technicians.
Other activities will include:
Postdoctoral candidates must have a PhD in Pharmacology, Chemistry or a related discipline, and documented experience in ADME/PK in drug discovery and development for cancer. The candidate must have experience involving standard molecular biology techniques including protein biochemical methods and cell culture. Diverse phenotypic and mechanistic assays applied to neuroscience are highly desirable.
Candidate must also document ability to evaluate proposed investigational projects, in vitro and in-vivo. The successful candidate must have a track record of publications in high-impact journals (first or co-first author) within the field of expertise. Interested applicants should submit a cover letter summarizing professional experience, a curriculum vitae, and contact information for three references.
To apply, please visit: https://recruit.apo.ucla.edu/JPF08383
The University of California is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, age or protected veteran status. For the complete University of California nondiscrimination and affirmative action policy, see: UC Nondiscrimination & Affirmative Action Policy, https://policy.ucop.edu/doc/4000376/DiscHarassAffirmAction
jeid-ed4f4ac8302a4343853fb35ec3ae0433
UCLA is known worldwide for the breadth and quality of its academic, research, health care, cultural, continuing education and athletic programs. UCLA offers undergraduate degrees in more than 127 majors and graduate degrees in 198 program areas. UCLA has 11 highly regarded professional schools. Eight are ranked among the nation's top 15 in their field by U.S. News & World Report. UCLA is consistently among the most popular campus in the nation for undergraduate applicants. The University of California is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employment without regard to age, race, color, religion, sex, national origin, disability, or protected veteran status. Benefits:UCLA offers a comprehensive benefits package, including an average of three weeks' vacation per year; an average of 12 days per year sick leave; 13 paid holidays per year; health, dental and optical benefits; life insurance; disability insurance; the University of California Retirement Plan with 5 year vesting and various voluntary UC Savings Plans. There are also special programs and privileges available, such as accessibility to cultural and recreational programs, athletic events, and the University Credit Union.
More Jobs from This Employer
https://careercenter.aalas.org/jobs/18478066/postdoctoral-scholar-drug-discovery-for-glioblastoma-and-other-cns-malignancies
Loading. Please wait.
Powered By
